tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Chang, 98 are a BUY (65.33%), 52 are a HOLD (34.67%).
Analyst Jonathan Chang, currently employed at LEERINK, carries an average stock price target met ratio of 52.81% that have a potential upside of 40.5% achieved within 237 days.
Jonathan Chang’s has documented 279 price targets and ratings displayed on 22 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on NBTX, at 04-Jun-2026.
Analyst best performing recommendations are on REPL (REPLIMUNE GROUP).
The best stock recommendation documented was for REPL (REPLIMUNE GROUP) at 4/13/2026. The price target of $2 was fulfilled within 1 day with a profit of $2.76 (57.98%) receiving and performance score of 579.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$1
$-0.01 (-0.99%)
$4
2 years 11 months 2 days ago
(10-Aug-2023)
3/4 (75%)
$0.18 (21.95%)
245
Buy
$5
$3.99 (395.05%)
3 years 6 months 9 days ago
(03-Jan-2023)
0/2 (0%)
$3.33 (199.40%)
Buy
$9
$8.22 (1053.85%)
$9
3 years 8 months 4 days ago
(09-Nov-2022)
2/3 (66.67%)
$1.29 (98.13%)
340
Hold
$3
$1.99 (197.03%)
4 years 2 months 3 days ago
(09-May-2022)
1/5 (20%)
$1.46 (94.81%)
377
Buy
$6
$5.22 (669.23%)
$16
7 years 2 months 6 days ago
(07-May-2019)
1/3 (33.33%)
$6.36 (92.59%)
388
Which stock is Jonathan Chang is most bullish on?
Which stock is Jonathan Chang is most reserved on?
What Year was the first public recommendation made by Jonathan Chang?
